MPLT: SEC Form 10-Q filed by MapLight Therapeutics Inc.
Stocks in this Quantisnow insightHealth Care
Full content unavailable. See the original source below.
Historical context for MPLT
Across the 3 sessions after earlier MPLT headlines, the stock closed higher 2 times and lower 1 times, with a median move of 5.3% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | MPLT | SPY |
|---|---|---|---|
| Dec 4, 2025 | MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress | +8.4% | +0.1% |
| Nov 21, 2025 | Morgan Stanley initiated coverage on MapLight Therapeutics with a new price targetand 3 other headlines that session | +5.3% | +1.0% |
| Oct 29, 2025 | MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares | -1.2% | +0.0% |
Quantisnow market dataNASDAQ
MPLT
MapLight Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2025
Get push alerts for MPLT
Full MPLT profile on Quantisnow Follow MPLT and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time